BioCentury

12:43 AM GMT, Aug 12, 2009
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Clinical News

Genmab reports first-line CLL data for Arzerra

Genmab A/S (CSE:GEN) said top-line data showed 500 and 1,000 mg

Read the full 116 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.